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Short Abstract 
A rapid screening method for detection of chemicals with juvenile hormone 
(JH)-activity was developed using adult Daphnia magna based on the phenomenon of 
induction of male offspring. However, JH-responsive genes in the ovary are still largely 
undescribed. Here, we conducted comparative microarray analyses using ovaries treated 
with fenoxycarb (artificial JH agonist) or methyl farnesoate (a putative innate JH in 
daphnids) to elucidate responses to JH agonists in ovary, including developing oocytes, 
at a JH-sensitive period for male sex determination. 
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Short title: Ovarian transcriptome of Daphnia magna 
Abstract 
The freshwater zooplankton Daphnia magna has been extensively employed in 
chemical toxicity tests such as OECD Test Guidelines 202 and 211. Previously, it has 
been demonstrated that treatment of juvenile hormones (JHs) or their analogs to female 
daphnids can induce male offspring production. Based on this finding, a rapid screening 
method for detection of chemicals with JH-activity was recently developed using adult 
D. magna. This screening system determines whether a chemical has JH-activity by 
investigating the male offspring inducibility. Although this is an efficient 
high-throughput short-term screening system, much remains to be discovered about 
JH-responsive pathways in the ovary, and whether different JH-activators act via the 
same mechanism. JH-responsive genes in the ovary including developing oocytes are 
still largely undescribed. Here, we conducted comparative microarray analyses using 
ovaries from Daphnia magna treated with fenoxycarb (Fx; artificial JH agonist) or 
methyl farnesoate (MF; a putative innate JH in daphnids) to elucidate responses to JH 
agonists in ovary, including developing oocytes, at a JH-sensitive period for male sex 
determination. We demonstrate that induction of hemoglobin genes is a well-conserved 
response to JH even in the ovary, and a potential adverse effect of JH agonist is 
suppression of vitellogenin gene expression, that might cause reduction of offspring 
number. This is the first report demonstrating different transcriptomics profiles from MF 
and an artificial JH agonist in D. magna ovary, improving understanding the 
tissue-specific mode-of-action of JH. 
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Introduction 
The cladoceran crustacean genus Daphnia is a model freshwater zooplankton 
forming the basis of a fundamental food-chain network in aquatic ecosystems. They 
have been used for ecological, developmental, evolutionary, and ecotoxicological 
studies, since they have unique and suitable features including; highly-diverged species 
around the world; ease of manipulation in the laboratory; production of genetically 
identical offspring by parthenogenesis; and, high-sensitivity to chemicals released into 
the natural environment. For ecotoxicological research, Daphnia magna has been used 
as a model species by the Organization for Economic Co-operation and Development 
Test Guidelines OECD TG202 (acute toxicity test; OECD, 1998) and TG211 (chronic 
toxicity test; OECD, 2004). Based on these toxicological tests, extensive data on effects 
of various chemicals have been accumulated for D. magna (Leiss et al., 2005), although 
as yet there is limited information on the modes-of-action of each chemical in Daphnia. 
 Describing the molecular impact of chemicals upon an organism is required to 
elucidate the chemical-specific mode-of-action of the toxic effects. For this reason, 
transcriptomic technologies have recently been applied for ecotoxicology to facilitate 
understanding the causal relationship between chemical exposure and its molecular 
adverse effects (Waters and Fostel, 2004; Poynton et al., 2007). Application of 
microarray and high-throughput sequencing technology to ecotoxicology has been 
termed “ecotoxicogenomics” (Snape et al., 2004; Iguchi et al., 2006). Focusing on 
Daphnia studies, transcriptomic approaches (e.g., microarray and RNA-seq) have 
contributed to accumulating fundamental knowledge about molecular impacts of 
chemicals. For example, D. magna microarray analysis has been conducted by several 
research groups (Watanabe et al., 2008; Poynton et al., 2007; Connon et al., 2008; 
Toyota et al., 2014; Abe et al., 2015a). Additionally, RNA-seq analyses enable us to 
more comprehensively and easily identify candidate transcripts and signaling pathways 
responding to chemical exposure (Toyota et al., 2015b). 
 Daphnia species are known to switch reproductive strategy between 
parthenogenesis and sexual reproduction in response to changing environmental 
conditions within their habitat. They produce, in general, female offspring under 
favorable environmental conditions. However, they begin to produce exclusively male 
offspring in response to unsuitable environmental conditions such as shortened 
day-length, low temperature, lack of nutrients, and crowding (referred to as 
environmental sex determination). Sexual reproduction then occurs to produce resting 
eggs, which remain viable for long periods, in excess of a century in some cases, in 
adverse environments such as dry and freezing conditions (Hobæk and Larsson, 1990; 
Kleiven et al., 1992; Smith, 1915; Toyota et al., 2015b).  
 Previously, it has been demonstrated that treatment of juvenile hormones 
(JHs) or their analogs to female daphnids could induce male offspring production even 
under female-producing conditions (Olmsted and LeBlanc, 2002; Tatarazako et al., 
2003). Additionally, we have demonstrated that endogenous methyl farnesoate (MF; a 
putative innate JH molecule in daphnids) is likely increased when mother produces 
male offspring (Toyota et al., 2015a).  
The induction of males following JH agonist exposure has become a useful 
endpoint for screening of chemicals with JH activity. This approach has been adopted 
for the OECD Validation Management Group for Ecotoxicity testing (OECD VMGeco), 
and added as a new endpoint in the OECD TG211 ANNEX 7 to detect JH-like activity 
(OECD, 2012). Furthermore, the JH-sensitive period for male sex determination in 
daphnids has been clarified as an oocyte maturation stage within the ovary (Kato et al., 
2011; Toyota et al., 2015a). Based on this finding, a rapid screening method for 
detection of chemicals with JH-activity was recently developed by using adult D. 
magna. This screening system can validate whether an arbitrary chemical has 
JH-activity by investigating the male offspring inducibility (Abe et al., 2015b). 
Although this short-term screening system will be able to dramatically improve testing 
throughput, JH-responsive genes regulating the physiological response and male 
induction in the ovary, including developing oocytes, at a JH-sensitive period are still 
largely unknown. Therefore, in this study, in order to detect JH-responsive genes, we 
conducted comparative microarray analyses using two kinds of JH chemical; 
fenoxycarb (an artificial JH agonist) and MF in D. magna ovaries. 
 
 
Materials and methods 
Daphnia strain and rearing conditions 
 The Daphnia magna strain (NIES clone) was obtained from the National 
Institute for Environmental Studies (NIES; Tsukuba, Japan) (Tatarazako et al., 2003). 
The strain originated from the Environmental Protection Agency (USA) and was 
maintained for more than 15 years at NIES. The synthetic M4 growth medium was used 
(Elendt and Bias, 1990). Cultures of 20 individuals per liter were incubated at 20±1°C 
under a 14-h light/10-h dark photoperiod. A 0.01-ml suspension of 4.3 x 10
8
 cells ml
−1
 
Chlorella (Chlorella vulgaris) was added daily to each culture.   
 
Chemicals and concentrations 
 Fenoxycarb (Fx) and methyl farnesoate (MF) were used as JH agonists in this 
study. Their chemical structures are shown in Figure 1A. Fx and dimethyl formamide 
(DMF) were obtained from Wako Pure Chemical Industries Ltd. (Osaka, Japan). MF 
was obtained from Echelon Bioscience (Salt Lake City, UT, USA). Experiments were 
conducted at the nominal concentrations of 2 ppb and 200 ppb for Fx and MF, 
respectively, dissolved in DMF. Those concentrations were decided according to 
previous studies (Tatarazako et al., 2003; Oda et al., 2005). Solvent DMF concentration 
in all test solutions was less than 0.01% v/v. 
 Daphnia magna oligonucleotide microarray 
A custom 4×44k oligonucleotide microarray was developed (Agilent 
Technologies, Earray Design ID: 020586). This microarray was designed from our 
developed expressed sequence tag (EST) database containing ~11k transcripts 
(Watanabe et al., 2005; 2007; 2008). Four probes were generally designed to each 
transcript sequence and the oligonucleotides (60 mers) were selected using the Agilent 
web design application (http://earray.chem.agilent.com/earray). Details of the platform 
design of the D. magna microarray and raw intensity values for each microarray are 
available at Gene Expression Omnibus with accession number GPL17297, series 
GSE81083. 
 
RNA extraction and hybridization 
20 individuals were cultured in 1 L of rearing medium with Fx or MF treatment. 
They were sacrificed at 2-3 weeks age, during the MF-sensitive period for male sex 
determination of the developing oocytes (Kato et al., 2011). Ovary samples consisted of 
three individuals per replicate, and quadruplicates were prepared for both Fx and MF 
treatments, respectively. Harvested ovaries were homogenized using a physcotron 
NS-310E (Nichion, Tokyo, Japan). Total RNA was extracted by TRIZOL reagent 
(Invitrogen, Tokyo, Japan), and purified using the RNeasy Micro Kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s protocols and including 
RNase-free DNase (Qiagen) treatment. The quality and concentration of 
total RNA was determined by NanoDrop (Thermo Fisher Scientific, 
Waltham, MA, USA) and 2100 Bioanalyzer (Agilent Technologies, 
Santa Clara, CA, USA).  
500 ng of total RNA were prepared for hybridization using the Quick 
Amp Labeling Kit and One-color RNA Spike-in kit (Agilent Technologies), and 
purified using the RNeasy Micro Kit (Qiagen) following the manufacturer’s 
protocol. The quality of Cyanine3-labeled complementary RNA (cRNA) was 
analyzed using the 2100 Bioanalyzer. 165 µg of Cyanine3-labeled cRNA were 
hybridized to the custom 4x44k D. magna microarray according to the 
manufacture’s protocol. After 17 h incubation at 65oC with rotation, the 
microarrays were washed with Gene Expression Wash Buffer Kit (Agilent 
Technologies). DNA microarrays were scanned using a GenePix 4000B scanner 
(Molecular Devices, Sunnyvale, CA, USA) at 5 µm resolution. The signal 
intensity of the spots was digitized using the microarray imager software 
(Combimatrix Molecular Diagnostics, Irvine, CA, USA).  
 
 
Differential gene expression analysis 
Data were input to Genespring v7.3 (Agilent), filtered to remove 
low-intensity features and quantile-normalised with geWorkbench (Floratos et 
al., 2010). SAM differential gene expression analysis (Tusher et al, 2001) was 
conducted within MeV (Saeed et al., 2003). Comparisons were made between 
control and treated groups, with a fold change of 1.5 or greater and FDR<0.1 considered 
significant.   
 
Gene ontology enrichment analysis 
 GO annotations were assigned to this microarray previously (Toyota et al., 
2014). GO enrichment analysis was carried out using the gene score resampling method 
in ErmineJ (v3.0.2) with full resampling of average of fold change used as gene scores 
(Lee et al., 2005). From 5,201 contigs or clones (total 10,135) bearing at least one GO 
term, GO subsets containing between 5 and 150 genes were considered in this analysis, 
and GO terms with a Benjamini-Hochberg FDR < 0.1 were defined as significant. 
 
 
Results 
Ovarian gene expression profile in response to fenoxycarb treatment 
 Microarray analyses were conducted using two kinds of JH agonist (Fx and 
MF), independently. Fx concentration was 2 ppb, which is able to induce male offspring 
exclusively (Tatarazako et al., 2003). Based on quality check of signal intensity of spots 
(detail in Materials and methods), we removed one replicate each from Fx and DMF 
(solvent control) treatments, resulting in analysis of this microarray data as triplicate 
samples (Fig. 1B). 
 The number of differentially expressed ovarian genes (DEGs; fold change < 
1.5 and FDR < 0.1) was 41 transcripts (77 probes) in response to 2 ppb Fx treatment; 26 
(52 probes) up-regulated and 15 (25 probes) down-regulated (Fig. 2; Table S1). 
Furthermore, cuticle- and cytochrome-related genes were up-regulated, whereas 
hemoglobin-, collagen-related and vitellogenin fused with superoxide dismutase genes 
were down-regulated (Table 1; Table S1). Additionally, gene ontology (GO) 
enrichment analysis showed that GO terms related to hemoglobin (e.g., oxygen 
transport, heme binding, and hemoglobin complex) and vitellogenin (e.g., superoxide 
metabolic process, and lipid transporter activity) were varied statistically significantly 
(Table 3).  
 
Ovarian gene expression profile in response to methyl farnesoate treatment  
 Ovarian microarray analysis was performed following 200 ppb MF treatment, 
which is a sufficient concentration for 100% male offspring induction (Tatarazako et al., 
2003). The number of DEGs in response to MF treatment was 41 transcripts (82 
probes); 32 (60 probes) up-regulated and 9 (22 probes) down-regulated (Fig. 2; Table 
S2). Although several already-known JH-responsive genes encoding cytochrome b5, 
trehalase and hemoglobin were differentially expressed in response to MF treatment as 
well as Fx, vitellogenin-related genes were not changed (Tables 2 and 3). Additionally, 
several novel JH-responsive candidates responded only to MF treatment; for example, 
genes encoding chk1 checkpoint-like protein, aquaporin, and sterol desaturase (Tables 2 
and S2). Moreover, 8 transcripts (cytochrome b5, thioredoxin domain-containing 
protein 17, trehalase, and 5 unidentified genes) were up-regulated by both Fx and MF 
treatments (Fig. 2; Table 3). 
In order to functionally overview the ovarian MF-responsive genes, GO 
enrichment analysis was conducted. Changes in hemoglobin-related GO terms were 
more statistically significant with MF treatment than Fx treatment (e.g., heme binding 
and tetrapyrrole binding). Moreover, cuticle- and sugar transport-related terms were 
identified as statistically significant following MF treatment (Table 4). 
 
 
Discussion 
 We demonstrated that differentially expressed gene profiles in response to Fx 
and MF treatments were different in D. magna ovary, consistent with our previous 
microarray study using whole-bodies of D. magna neonates treated by three JH agonists 
(Toyota et al., 2014). In order to more comprehensively overview the trends of gene 
expression profiles in response to Fx and MF treatments, we conducted GO enrichment 
analysis, successfully identifying the hemoglobin gene family as varying in expression 
in response to both Fx and MF treatments. Interestingly, hemoglobin genes are 
highly-duplicated, forming a tandemly duplicated gene cluster in the Daphnia genome 
(Colbourne et al., 2011). Additionally, several previous studies demonstrated that 
hemoglobin genes of daphnids show high JH-responsiveness based on alteration of gene 
expression level (Eads et al., 2008; Gorr et al., 2006; Hannas et al., 2011). Although, 
based on those data, it has been considered that hemoglobin genes are up-regulated by 
JH agonist treatment, our recent microarray and RNA-seq analyses demonstrated that 
hemoglobin genes were often down-regulated in the whole-body of neonate treated by 
other JH agonists; methoprene and epofenonane (Toyota et al., 2014), and in the 
whole-body or ovary of adult D. pulex treated by MF (Toyota et al., 2015b) (Table S3). 
Additionally, the current study showed that ovarian hemoglobin genes were 
down-regulated by both Fx and MF treatments. Surprisingly, expression patterns 
showed the opposite when whole adult D. magna and D. pulex were treated with 200 
ppb MF (Hannas et al., 2011; Toyota et al., 2015b) (Table S3). These data imply that, 
although hemoglobin genes are undoubtedly JH-responsive genes in daphnids, the 
regulation of their expression pattern is tissue-specific and might also be affected by 
life-stage, species, chemical sensitivity and selectivity. 
According to the OECD TG211 ANNEX 7 (OECD, 2004), toxic impacts of 
Fx and MF to fertility and male-inducibility on D. magna have been investigated as well 
as that of other JH agonists. Those studies revealed that Fx has high repro-toxic effects 
such as decreasing the number of offspring and increasing the male sex ratio of 
offspring even at less than 1.0 ppb. Although, likewise, repro-toxic effects of MF have 
been clarified, it was more than 1000 times less potent than Fx (Tatarazako et al., 2003; 
Oda et al., 2005). It has been reported that binding abilities of ligand (JH molecule) to 
the JH receptor complex is quite different between JH agonists, and that concentrations 
triggering the conjugation of JH agonist to JH receptor complex were consistent with 
each male-inducible concentration estimated by OECD TG211 test data (Miyakawa et 
al., 2013). In other words, the difference of male-inducibility among JH agonists could 
be explained by ligand selectivity of JH receptor complex. Despite these findings, the 
cause of differential toxic effects on fertility among JH agonists is still largely unknown. 
In this study, DEG analysis revealed that vitellogenin-related genes (e.g., vitellogenin 
fused with superoxide dismutase) were apparently down-regulated in response to Fx 
treatment, but not to MF treatment. This tendency was more clearly shown by GO 
enrichment analysis. Moreover, similar to Fx exposure, it has been reported that 
expression levels of vitellogenin genes were decreased by other JH agonists in 
whole-body of juvenile individuals (Tokishita et al., 2006; Kim et al., 2011) and adult 
ovaries (Toyota et al., 2015b); however, interestingly, one report showed that expression 
level of vitellogenin gene was not affected by Fx treatment in adult female whole-body 
(Hannas et al., 2011). These data indicate that responsiveness of vitellogenin gene to JH 
is different depending on sample features such as age, tissue, and JH agonists treated. 
The vitellogenin of daphnids contains the superoxide dismutase (SOD)-like domain and 
might play a crucial role in the protection of oocytes against oxidative stress (Kato et 
al., 2004). Additionally, in general, vitellogenin is known as a precursor of yolk protein 
which is an essential factor for oocyte/egg maturation and embryo development. 
Therefore, it could be suggested that the reduction of offspring number in response to 
JH agonists might be due to suppression of vitellogenin-related expression in ovary. 
Although, to date, underlying mechanisms connecting JH agonist exposure and 
suppression of vitellogenin gene expression are still unclear, elucidation of those 
regulatory mechanisms will provide us important knowledge about the mode-of-action 
of JH agonist toxicity. 
Although only eight transcripts could be identified as common up-regulated 
DEGs, expression profiles of two genes encoding cytochrome b5 and contig854 
(without annotation) were consistent with our previous transcriptome analysis using 
adult whole-body and ovary of D. pulex (Toyota et al., 2015b), suggesting that these are 
strong candidates for well-conserved JH-responsive genes in daphnids. The expression 
level of contig1856 was up-regulated in this study; however, our previous transcriptome 
data showed that it was down-regulated (Toyota et al., 2015b). Trehalase is a glycoside 
hydrolase enzyme and catalyzes the conversion of trehalose to glucose. A recent study 
using red flour beetle Tribolium castaneum revealed that knock-down of JH acid 
methyltransferase (JHAMT) involved in JH synthesis represses trehalase gene 
expression, suggesting that JH regulates trehalose homeostasis (Xu et al., 2013). 
Therefore, in the daphnids, trehalase and trehalose homeostasis might also be 
downstream targets of JH signaling. Thioredoxin domain-containing protein 17 
(TXNDC17) has peroxidase activity and could contribute to the removal of hydrogen 
peroxide generated by redox reactions (Jeong et al., 2004). Up-regulation of TXNDC17 
might play important role in protection of ovary and/or oocyte from oxidative stress, 
since the amount of oxidant is increased by up-regulation of hemoglobin genes in 
whole-body responsive to JH treatment (Table S3). Furthermore, three other transcripts 
(contig538, contig2690, and contig3811) are novel candidates for JH-responsive 
transcripts, although their functions are still unknown. 
Finally, several MF-specific responsive candidates were identified, including 
genes encoding chk1 checkpoint-like protein, aquaporin, and sterol desaturase. Chk1 
checkpoint protein acts for monitoring the DNA quality and can control delay in, or 
arrest of, the cell cycle at multiple points during the cycle (Purdy et al., 2005). 
Although, to date, its function in oogenesis of daphnids responding to JH remains 
unknown, a recent study revealed that JH activates other checkpoint gene, 
cell-division-cycle 6 (cdc6), in vitellogenesis and oogenesis of migratory locust (Wu et 
al., 2016). These results suggest that regulation of the cell cycle can be altered by MF 
exposure in daphnids. 
Taken together, in the current study, we discovered genes responsive to Fx or 
MF treatments by microarray analysis. Furthermore, we demonstrated that the 
hemoglobin genes are well-conserved JH-responsive elements even in the ovary, and a 
potential repro-toxic mechanism of JH agonists is suppression of vitellogenin gene 
expression, potentially leading to reduction of offspring number. Despite these findings, 
no candidate gene clearly involved in control of male induction was identified. The 
possible reason is that function and annotation of genes in D. magna are still largely 
undescribed, although recent progress in high-throughput sequencing technology paves 
the way for the ecotoxicogenomics research using non model organisms including 
daphnid species. Indeed, several unknown-function genes were contained in our current 
candidate DEGs. In order to overcome this limitation of gene annotation, large-scale D. 
magna transcriptome data has rapidly been accumulated (Orsini et al., 2016), making 
more efficient screening of genes involved with male induction and JH-response 
possible. Our findings provide fundamental information for understanding the alteration 
of tissue- and chemical-specific transcriptome in response to JH agonist treatment 
accompanied by male offspring production. 
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Table 1.  
Representative up- or down-regulated transcripts in response to fenoxycarb treatment (FC > 1.5, q < 0.1). Refer to Supplemental Table 
S1 for complete listing. 
Probe ID Hit Contig Description (BlastX) Fold Change (unlogged) q value 
Up-regulation 
DM08957_1 IGU001_0007_B05.r beta-ig-h3 fasciclin 1.77 <0.001 
DMAG0001S00004120 Contig4120 cub and sushi domain-containing protein 3 1.53 0.041 
DMAG0001S00001893 Contig1893 cub and sushi domain-containing protein 3-like 1.55 0.067 
DM09619_2 WTH001_0003_O02.f cuticular protein analogous to peritrophins 3-a1 1.90 <0.001 
DM02762_3 Contig5168 cysteine-rich secretory protein 2 2.20 <0.001 
DM05678_1 Contig4172 cytochrome b5 1.59 0.056 
DMAG0001S00006990 dm005p22.r minichromosome maintenance deficient 8 ( cerevisiae) 1.50 0.088 
DMAG0001S00004449 Contig4449 papilin 3.14 <0.001 
DM12229_2 Contig3209 phospholipase a2 1.63 0.024 
DM06173_2 Contig2484 ras suppressor protein 1 1.52 0.054 
DM11265_2 dm027b16.f retinaldehyde-binding protein 1-like protein 1 1.79 0.059 
DMAG0001S00001937 Contig1937 stress protein ddr48 (dna damage-responsive protein 48) 1.75 0.099 
DMAG0001S00004737 Contig4737 thioredoxin domain-containing protein 17 1.63 <0.001 
DM05149_2 dm037g17.f xylose isomerase 2.11 <0.001 
     Down-regulation 
DMAG0001S00004100 Contig4417 2-domain hemoglobin protein subunit 0.13 0.086 
DMAG0001S00005307 IGU001_0006_H04.f 2-domain hemoglobin protein subunit 0.14 0.086 
DMAG0001S00005655 IGU001_0049_F06.f 2-domain hemoglobin protein subunit 0.15 0.086 
DMAG0001S00001119 Contig1119 aplp_locmi ame: full=apolipophorins contains 0.14 0.086 
DM06048_1 Contig4848 collagen alpha-1 chain 0.37 0.023 
DMAG0001S00001196 Contig1196 collagen alpha-2 0.46 0.086 
DM06590_1 Contig2473 steroid dehydrogenase 0.43 0.086 
DM14629_2 Contig373 transducin -like 1 x-linked receptor 1-like 0.64 0.086 
DMAG0001S00007057 dm006p15.f vitellogenin fused with superoxide dismutase 0.29 0.086 
DMAG0001S00008423 dm026o19.f vitellogenin fused with superoxide dismutase 0.17 0.086 
DM01857_2 dm043j10.r vitellogenin fused with superoxide dismutase 0.16 0.086 
DMAG0001S00009929 dm058b09.f vitellogenin fused with superoxide dismutase 0.16 0.086 
 
 
 
 
Table 2.  
Representative up- or down-regulated transcripts in response to methyl farnesoate treatment (FC > 1.5, q < 0.1). Refer to Supplemental 
Table S2 for complete listing. 
Probe ID Hit Contig Description (BlastX) Fold Change (unlogged) q value 
Up-regulation 
DM04056_2 Contig1848 alpha-mannosidase 2 2.87 0.086 
DM01384_3 Contig1921 angiotensin converting enzyme 2.16 0.030 
DM02550_3 Contig5000 aquaporin 3-like 3.58 <0.001 
DM05943_2 dm051j21.f aquaporin isoform cra_b 3.67 0.020 
DM08718_2 Contig4485 ccaat enhancer binding protein 2.61 <0.001 
DMAG0001S00009113 dm040h12.f chk1 checkpoint-like protein 3.00 <0.001 
DM04958_1 Contig4172 cytochrome b5 1.86 0.055 
DM10603_1 Contig1639 lim domain-binding protein 1.85 <0.001 
DM09817_2 Contig817 microsomal dipeptidase 1.59 0.086 
DM05459_1 Contig5232 midline fasciclin 1.78 0.018 
DM02339_3 Contig2588 phosphatidylserine decarboxylase 1.53 0.085 
DMAG0001S00004737 Contig4737 thioredoxin domain-containing protein 17 1.74 <0.001 
DM00993_1 dm009m07.r trehalase 1.78 0.091 
     Down-regulation 
    
DM11523_1 Contig4100 2-domain hemoglobin 0.10 0.079 
DM08378_2 Contig3556 camp-dependent protein kinase r2 0.49 0.064 
DM05703_1 dm005p22.r minichromosome maintenance deficient 8 ( cerevisiae) 0.37 0.054 
DM03522_2 Contig1132 sterol desaturase 0.25 0.045 
 
 
 
 
 
 
 
 
 
 
 
Table 3.  
Common up-regulated transcripts in response to both treatments (FC > 1.5, q < 0.1). 
Probe ID Hit Contig Description (BlastX) 
Fx MF 
Fold Change q value 
Fold 
Change q value 
DM05678_1 
Contig4172 cytochrome b5 
1.59  0.056 - - 
DMAG0001S00004172 1.59  0.056 - - 
DM04958_1 - - 1.86  0.055 
DM10334_1 - - 2.10  0.086 
DMAG0001S00004737 
Contig4737 thioredoxin domain-containing protein 17 
1.63  <0.001 1.74  <0.001 
DM11877_1 1.65  0.024 1.68  <0.001 
DM00993_1 dm009m07.r trehalase - - 1.78  0.091 
DMAG0001S00001856 
Contig1856 
hypothetical protein DAPPUDRAFT_309304 
[Daphnia pulex] 
9.62  <0.001 6.08  <0.001 
DM07245_2 17.95  <0.001 7.51  <0.001 
DM07245_1 - - 4.65  <0.001 
DMAG0001S00000854 
Contig854 
hypothetical protein DAPPUDRAFT_308669 
[Daphnia pulex] 
1.76  <0.001 - - 
DM08418_1 2.70  <0.001 2.45  <0.001 
DM08418_2 - - 2.21  <0.001 
DM06798_1 Contig538 hypothetical protein DAPPUDRAFT_303931 1.80  <0.001 1.65  0.091 
[Daphnia pulex] 
DM06100_2 
Contig2690 Unknown 
3.77  <0.001 6.10  0.086 
DM06100_1 8.99  <0.001 22.84  0.053 
DMAG0001S00003811 Contig3811 Unknown - - 1.52  0.031 
 
 
 
 
 
 
 
 
 
 
 
Table 4.  
List of GO terms varied in response to both treatments. 
GO Name GO_ID Same As 
Corrected p value 
Fx MF 
Biological Process 
   
oxygen transport GO:0015671 
GO:0005344, 
GO:0019825 0.0918 <0.0001 
gas transport GO:0015669 
 
0.1102 <0.0001 
superoxide metabolic process GO:0006801 
 
0.0128 0.3504 
reactive oxygen species metabolic process GO:0072593 
 
0.0608 0.4771 
lipid transport GO:0006869 
 
0.0875 0.1070 
     Molecular Function 
    
oxygen transporter activity GO:0005344 
GO:0015671, 
GO:0019825 0.0810 <0.0001 
oxygen binding GO:0019825 
GO:0015671, 
GO:0005344 0.0810 <0.0001 
heme binding GO:0020037 
 
0.5139 <0.0001 
tetrapyrrole binding GO:0046906 
 
0.4405 <0.0001 
oxidoreductase activity, acting on single donors with GO:0016702 
 
1.0000 0.0887 
incorporation of molecular oxygen, incorporation of two atoms 
of oxygen 
oxidoreductase activity, acting on single donors with 
incorporation of molecular oxygen GO:0016701 
 
1.0000 0.0985 
lipid transporter activity GO:0005319 
 
0.0634 0.0853 
structural constituent of cuticle GO:0042302 
 
0.0622 0.0114 
chitin binding GO:0008061 
 
0.5857 0.0288 
carbohydrate transmembrane transporter activity GO:0015144 GO:1901476 1.0000 0.0783 
carbohydrate transporter activity GO:1901476 GO:0015144 1.0000 0.0783 
transferase activity, transferring pentosyl groups GO:0016763 
 
1.0000 0.0950 
     Cellular Function 
    extracellular region GO:0005576 
 
0.0056 <0.0001 
hemoglobin complex GO:0005833 
 
0.0718 <0.0001 
cytosolic part GO:0044445  1.0000 <0.0001 
 
 
 
 
Supplemental table S1.  
Up- or down-regulated transcripts in response to fenoxycarb treatment (FC > 1.5, q < 0.1). 
Probe ID 
Hit Contig Description (BlastX) 
Fold Change (unlogged) 
q 
value 
Up-regulation 
DM01917_2 Contig1411 hypothetical protein DAPPUDRAFT_224365 [Daphnia pulex] 1.72 0.024 
DM04940_1 Contig1818 Unknown 1.76 0.024 
DM04940_2 Contig1818 Unknown 1.76 0.041 
DM07245_2 Contig1856 hypothetical protein DAPPUDRAFT_309304 [Daphnia pulex] 17.95 <0.001 
DMAG0001S00001856 Contig1856 hypothetical protein DAPPUDRAFT_309304 [Daphnia pulex] 9.62 <0.001 
DMAG0001S00001893 Contig1893 cub and sushi domain-containing protein 3-like 1.55 0.067 
DMAG0001S00001937 Contig1937 stress protein ddr48 (dna damage-responsive protein 48) 1.75 0.099 
DM06173_2 Contig2484 ras suppressor protein 1 1.52 0.054 
DM13504_2 Contig2536 hypothetical protein DAPPUDRAFT_302150 [Daphnia pulex] 2.15 0.024 
DM11193_1 Contig2536 hypothetical protein DAPPUDRAFT_302150 [Daphnia pulex] 3.13 <0.001 
DMAG0001S00002536 Contig2536 hypothetical protein DAPPUDRAFT_302150 [Daphnia pulex] 3.12 <0.001 
DM13504_1 Contig2536 hypothetical protein DAPPUDRAFT_302150 [Daphnia pulex] 2.53 <0.001 
DM06100_1 Contig2690 Unknown 8.99 <0.001 
DM06100_2 Contig2690 Unknown 3.77 <0.001 
DM12229_2 Contig3209 phospholipase a2 1.63 0.024 
DM03175_2 Contig3209 phospholipase a2 1.66 0.054 
DMAG0001S00003209 Contig3209 phospholipase a2 1.69 0.088 
DM07000_2 Contig3690 Unknown 2.61 0.099 
DMAG0001S00003864 Contig3864 hypothetical protein DAPPUDRAFT_49070 [Daphnia pulex] 1.59 0.024 
DM04523_1 Contig3864 hypothetical protein DAPPUDRAFT_49070 [Daphnia pulex] 1.63 <0.001 
DMAG0001S00004120 Contig4120 cub and sushi domain-containing protein 3 1.53 0.041 
DMAG0001S00004172 Contig4172 cytochrome b5 1.59 0.056 
DM05678_1 Contig4172 cytochrome b5 1.59 0.056 
DMAG0001S00004449 Contig4449 papilin 3.14 <0.001 
DM11877_1 Contig4737 thioredoxin domain-containing protein 17 1.65 0.024 
DMAG0001S00004737 Contig4737 thioredoxin domain-containing protein 17 1.63 <0.001 
DMAG0001S00004753 Contig4753 hypothetical protein DAPPUDRAFT_224638 [Daphnia pulex] 2.16 <0.001 
DM08270_1 Contig4753 hypothetical protein DAPPUDRAFT_224638 [Daphnia pulex] 2.06 <0.001 
DM02762_3 Contig5168 cysteine-rich secretory protein 2 2.20 <0.001 
DM02762_2 Contig5168 cysteine-rich secretory protein 2 2.18 <0.001 
DM02437_2 Contig5168 cysteine-rich secretory protein 2 2.18 <0.001 
DMAG0001S00005168 Contig5168 cysteine-rich secretory protein 2 2.18 <0.001 
DM02437_1 Contig5168 cysteine-rich secretory protein 2 2.14 <0.001 
DM02437_3 Contig5168 cysteine-rich secretory protein 2 2.09 <0.001 
DM06798_1 Contig538 hypothetical protein DAPPUDRAFT_303931 [Daphnia pulex] 1.80 <0.001 
DM08418_1 Contig854 hypothetical protein DAPPUDRAFT_308669 [Daphnia pulex] 2.70 <0.001 
DMAG0001S00000854 Contig854 hypothetical protein DAPPUDRAFT_308669 [Daphnia pulex] 1.76 <0.001 
DMAG0001S00006990 dm005p22.r minichromosome maintenance deficient 8 ( cerevisiae) 1.50 0.088 
DMAG0001S00008166 dm022l12.f Unknown 2.12 <0.001 
DM11265_2 dm027b16.f retinaldehyde-binding protein 1-like protein 1 1.79 0.059 
DM11265_1 dm027b16.f retinaldehyde-binding protein 1-like protein 1 1.62 0.078 
DMAG0001S00008430 dm027b16.f retinaldehyde-binding protein 1-like protein 1 1.75 0.088 
DM05149_2 dm037g17.f xylose isomerase 2.11 <0.001 
DMAG0001S00008977 dm037g17.f xylose isomerase 2.08 <0.001 
DM05149_1 dm037g17.f xylose isomerase 2.03 <0.001 
DMAG0001S00009463 dm047g18.f Unknown 2.18 0.041 
DM11275_1 dm047g18.f Unknown 2.04 <0.001 
DM08957_1 IGU001_0007_B05.r beta-ig-h3 fasciclin 1.77 <0.001 
DM08957_2 IGU001_0007_B05.r beta-ig-h3 fasciclin 1.68 <0.001 
DM09619_2 WTH001_0003_O02.f cuticular protein analogous to peritrophins 3-a1 1.90 <0.001 
DMAG0001S00005944 WTH001_0003_O02.f cuticular protein analogous to peritrophins 3-a1 1.72 <0.001 
DM09619_1 WTH001_0003_O02.f cuticular protein analogous to peritrophins 3-a1 1.66 <0.001 
     Down-regulation 
DMAG0001S00001119 Contig1119 aplp_locmi ame: full=apolipophorins contains 0.14 0.086 
DMAG0001S00001196 Contig1196 collagen alpha-2 0.46 0.086 
DM12094_2 Contig220 Unknown 0.48 0.086 
DM06590_1 Contig2473 steroid dehydrogenase 0.43 0.086 
DM06590_2 Contig2473 steroid dehydrogenase 0.40 0.086 
DM14629_2 Contig373 transducin -like 1 x-linked receptor 1-like 0.64 0.086 
DM12258_2 Contig4365 Unknown 0.65 0.086 
DMAG0001S00004365 Contig4365 Unknown 0.63 0.086 
DMAG0001S00004100 Contig4417 2-domain hemoglobin protein subunit 0.13 0.086 
DM06048_1 Contig4848 collagen alpha-1 chain 0.37 0.023 
DMAG0001S00007057 dm006p15.f vitellogenin fused with superoxide dismutase 0.29 0.086 
DMAG0001S00008423 dm026o19.f vitellogenin fused with superoxide dismutase 0.17 0.086 
DM03613_3 dm026o19.f vitellogenin fused with superoxide dismutase 0.14 0.086 
DM03613_1 dm026o19.f vitellogenin fused with superoxide dismutase 0.14 0.086 
DM01857_2 dm043j10.r vitellogenin fused with superoxide dismutase 0.16 0.086 
DMAG0001S00001655 dm043j10.r vitellogenin fused with superoxide dismutase 0.14 0.086 
DM11621_2 dm043j10.r vitellogenin fused with superoxide dismutase 0.14 0.086 
DM01857_1 dm043j10.r vitellogenin fused with superoxide dismutase 0.14 0.086 
DM11621_1 dm043j10.r vitellogenin fused with superoxide dismutase 0.14 0.086 
DM01857_3 dm043j10.r vitellogenin fused with superoxide dismutase 0.13 0.086 
DMAG0001S00009929 dm058b09.f vitellogenin fused with superoxide dismutase 0.16 0.086 
DMAG0001S00005307 IGU001_0006_H04.f 2-domain hemoglobin protein subunit 0.14 0.086 
DM08998_2 IGU001_0012_D09.f Unknown 0.19 0.086 
DM08998_1 IGU001_0012_D09.f Unknown 0.19 0.086 
DMAG0001S00005655 IGU001_0049_F06.f 2-domain hemoglobin protein subunit 0.15 0.086 
 
 
 
 
 
 
Supplemental table S2.  
Up- or down-regulated transcripts in response to methyl farnesoate treatment (FC > 1.5, q < 0.1). 
Probe ID 
Hit Contig Description (BlastX) 
Fold Change (unlogged) 
q 
value 
Up-regulation 
DM08098_2 Contig1409 
hypothetical protein DAPPUDRAFT_311096 
[Daphnia pulex] 3.22 <0.001 
DM01338_2 Contig1639 lim domain-binding protein 1.67 0.018 
DM10603_1 Contig1639 lim domain-binding protein 1.85 <0.001 
DM10603_2 Contig1639 lim domain-binding protein 1.75 <0.001 
DM01338_1 Contig1639 lim domain-binding protein 1.74 <0.001 
DMAG0001S00001639 Contig1639 lim domain-binding protein 1.56 <0.001 
DM04056_2 Contig1848 alpha-mannosidase 2 2.87 0.086 
DM07245_2 Contig1856 
hypothetical protein DAPPUDRAFT_309304 
[Daphnia pulex] 7.51 <0.001 
DMAG0001S00001856 Contig1856 
hypothetical protein DAPPUDRAFT_309304 
[Daphnia pulex] 6.08 <0.001 
DM07245_1 Contig1856 
hypothetical protein DAPPUDRAFT_309304 
[Daphnia pulex] 4.65 <0.001 
DM01384_3 Contig1921 angiotensin converting enzyme 2.16 0.030 
DM01384_1 Contig1921 angiotensin converting enzyme 1.99 0.031 
DM02339_3 Contig2588 phosphatidylserine decarboxylase 1.53 0.085 
DM06100_1 Contig2690 Unknown 22.84 0.053 
DM06100_2 Contig2690 Unknown 6.10 0.086 
DMAG0001S00002984 Contig2984 Unknown 3.25 0.012 
DM08692_1 Contig2984 Unknown 2.77 <0.001 
DM08692_2 Contig2984 Unknown 2.62 <0.001 
DMAG0001S00003104 Contig3104 
hypothetical protein DAPPUDRAFT_303742 
[Daphnia pulex] 1.52 0.090 
DM06987_2 Contig3285 
hypothetical protein DAPPUDRAFT_303367 
[Daphnia pulex] 1.55 0.012 
DM07199_1 Contig3481 Unknown 3.95 0.018 
DM07418_1 Contig3481 Unknown 6.12 0.020 
DM07199_2 Contig3481 Unknown 4.31 0.020 
DMAG0001S00003481 Contig3481 Unknown 3.95 0.031 
DM07418_2 Contig3481 Unknown 6.42 <0.001 
DM05204_1 Contig3580 
hypothetical protein DAPPUDRAFT_331983 
[Daphnia pulex] 16.84 0.093 
DMAG0001S00003632 Contig3632 
hypothetical protein DAPPUDRAFT_231816 
[Daphnia pulex] 2.93 0.053 
DM06179_2 Contig3632 
hypothetical protein DAPPUDRAFT_231816 
[Daphnia pulex] 5.01 0.054 
DM07000_1 Contig3697 Unknown 6.89 0.074 
DMAG0001S00003811 Contig3811 Unknown 1.52 0.031 
DM04958_1 Contig4172 cytochrome b5 1.86 0.055 
DM10334_1 Contig4172 cytochrome b5 2.10 0.086 
DMAG0001S00004485 Contig4485 ccaat enhancer binding protein 1.57 0.027 
DM08718_1 Contig4485 ccaat enhancer binding protein 2.21 0.031 
DM08718_2 Contig4485 ccaat enhancer binding protein 2.61 <0.001 
DMAG0001S00004737 Contig4737 thioredoxin domain-containing protein 17 1.74 <0.001 
DM11877_1 Contig4737 thioredoxin domain-containing protein 17 1.68 <0.001 
DM14953_1 Contig4790 Unknown 1.90 0.086 
DM02550_2 Contig5000 aquaporin 3-like 3.67 0.012 
DM02550_3 Contig5000 aquaporin 3-like 3.58 <0.001 
DM02550_1 Contig5000 aquaporin 3-like 3.39 <0.001 
DMAG0001S00005000 Contig5000 aquaporin 3-like 3.25 <0.001 
DM05459_1 Contig5232 midline fasciclin 1.78 0.018 
DM06798_1 Contig538 
hypothetical protein DAPPUDRAFT_303931 
[Daphnia pulex] 1.65 0.091 
DM09817_2 Contig817 microsomal dipeptidase 1.59 0.086 
DM08418_1 Contig854 
hypothetical protein DAPPUDRAFT_308669 
[Daphnia pulex] 2.45 <0.001 
DM08418_2 Contig854 
hypothetical protein DAPPUDRAFT_308669 
[Daphnia pulex] 2.21 <0.001 
DM00993_1 dm009m07.r trehalase 1.78 0.091 
DMAG0001S00008858 dm034j11.f Unknown 1.91 <0.001 
DMAG0001S00009113 dm040h12.f chk1 checkpoint-like protein 3.00 <0.001 
DM04846_2 dm046e14.f Unknown 1.57 <0.001 
DM05943_2 dm051j21.f aquaporin isoform cra_b 3.67 0.020 
DMAG0001S00009682 dm051j21.f aquaporin isoform cra_b 3.45 0.031 
DM01160_2 dm051j21.f aquaporin isoform cra_b 4.15 0.055 
DM05943_1 dm051j21.f aquaporin isoform cra_b 4.01 0.086 
DM09287_1 IGU001_0045_A04.f Unknown 1.53 0.027 
DM09591_1 WTH001_0003_F20.f Unknown 3.07 0.018 
DM09591_2 WTH001_0003_F20.f Unknown 3.60 0.031 
DMAG0001S00005915 WTH001_0003_F20.f Unknown 3.11 <0.001 
DMAG0001S00006450 WTH001_0012_C01.r 
hypothetical protein DAPPUDRAFT_45609 
[Daphnia pulex] 1.67 0.027 
     Down-regulation 
    
DM03522_1 Contig1132 sterol desaturase 0.30 0.045 
DM03522_3 Contig1132 sterol desaturase 0.29 0.084 
DM03522_2 Contig1132 sterol desaturase 0.25 0.045 
DM02956_2 Contig1132 sterol desaturase 0.25 0.084 
DM02956_3 Contig1132 sterol desaturase 0.24 0.075 
DMAG0001S00001132 Contig1132 sterol desaturase 0.22 0.084 
DM02956_1 Contig1132 sterol desaturase 0.19 0.064 
DM05290_1 Contig2478 
hypothetical protein DAPPUDRAFT_101535 
[Daphnia pulex] 0.52 0.064 
DM11240_1 Contig2647 Unknown 0.22 0.084 
DMAG0001S00003556 Contig3556 camp-dependent protein kinase r2 0.52 0.064 
DM08378_2 Contig3556 camp-dependent protein kinase r2 0.49 0.064 
DM02646_2 Contig3556 camp-dependent protein kinase r2 0.44 0.097 
DM02845_1 Contig4100 2-domain hemoglobin 0.24 0.084 
DM11523_2 Contig4100 2-domain hemoglobin 0.12 0.079 
DM11523_1 Contig4100 2-domain hemoglobin 0.10 0.079 
DM04574_1 Contig4811 
hypothetical protein DAPPUDRAFT_305103 
[Daphnia pulex] 0.06 0.064 
DMAG0001S00006990 dm005p22.r 
minichromosome maintenance deficient 8 
( cerevisiae) 0.38 0.064 
DM05703_1 dm005p22.r 
minichromosome maintenance deficient 8 
( cerevisiae) 0.37 0.054 
DMAG0001S00010206 dm065a02.f 
hypothetical protein DAPPUDRAFT_330570 
[Daphnia pulex] 0.15 0.064 
DM12494_1 dm065a02.f 
hypothetical protein DAPPUDRAFT_330570 
[Daphnia pulex] 0.14 0.084 
DM12494_2 dm065a02.f 
hypothetical protein DAPPUDRAFT_330570 
[Daphnia pulex] 0.10 0.090 
DMAG0001S00005739 WTH001_0001_B21.f Unknown 0.50 0.076 
 
 
 
 
Supplemental table S3.  
Summary of expression patterns of hemoglobin-related gene in response to JH agonists. 
 
 
 
Figure legends 
Figure 1. 
Chemical structure of fenoxycarb and methyl farnesoate (A) and schematic diagram of 
experimental procedure (B). 
 
Figure 2. 
Venn diagram representing the number of up-regulated (A) and down-regulated (B) 
contigs (probes) with significant expression change (FC > 1.5, q < 0.1) between treated 
and control Daphnia for fenoxycarb and methyl farnesoate treatments. 
 
 
 
 
 
